Lido Advisors, LLC Abbott Laboratories Transaction History

Lido Advisors, LLC

  • $20.3 Billion
  • Q3 2024

A detailed history of Lido Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Lido Advisors, LLC holds 6,500 shares of ABT stock, worth $747,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,500
Previous 133,374 95.13%
Holding current value
$747,695
Previous $13.9 Million 94.65%
% of portfolio
0.0%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.07 - $118.13 $72,350 - $85,407
-723 Reduced 0.54%
132,651 $15.1 Million
Q2 2024

Aug 14, 2024
SELL
$100.73 - $112.44 $795,464 - $887,938
-7,897 Reduced 5.59%
133,374 $13.9 Million
Q1 2024

May 15, 2024
BUY
$109.52 - $120.96 $412,561 - $455,656
3,767 Added 2.74%
141,271 $16.1 Million
Q4 2023

Feb 14, 2024
BUY
$90.19 - $110.4 $704,203 - $862,003
7,808 Added 6.02%
137,504 $15.1 Million
Q3 2023

Nov 14, 2023
SELL
$95.53 - $114.62 $4.35 Million - $5.22 Million
-45,553 Reduced 25.99%
129,696 $12.6 Million
Q2 2023

Aug 09, 2023
BUY
$100.78 - $112.29 $1.47 Million - $1.63 Million
14,558 Added 9.06%
175,249 $19.1 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $9.95 Million - $11.7 Million
102,737 Added 177.27%
160,691 $16.3 Million
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $441,268 - $517,675
-4,642 Reduced 7.42%
57,954 $6.36 Million
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $2.6 Million - $3.01 Million
-26,849 Reduced 30.02%
62,596 $6.06 Million
Q2 2022

Aug 15, 2022
BUY
$102.07 - $123.37 $398,889 - $482,129
3,908 Added 4.57%
89,445 $9.72 Million
Q1 2022

May 17, 2022
BUY
$114.02 - $139.04 $1.47 Million - $1.79 Million
12,902 Added 17.76%
85,537 $10.1 Million
Q4 2021

Feb 15, 2022
BUY
$115.53 - $141.46 $2.96 Million - $3.62 Million
25,624 Added 54.51%
72,635 $10.2 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $1.02 Million - $1.13 Million
-8,729 Reduced 15.66%
47,011 $5.56 Million
Q2 2021

Aug 12, 2021
BUY
$105.79 - $124.53 $641,616 - $755,274
6,065 Added 12.21%
55,740 $6.46 Million
Q1 2021

May 13, 2021
BUY
$108.84 - $128.23 $879,100 - $1.04 Million
8,077 Added 19.42%
49,675 $5.95 Million
Q4 2020

Feb 08, 2021
BUY
$105.0 - $114.42 $1.93 Million - $2.1 Million
18,371 Added 79.09%
41,598 $4.55 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $65,522 - $79,572
715 Added 3.18%
23,227 $2.53 Million
Q2 2020

Aug 12, 2020
BUY
$76.57 - $98.0 $372,130 - $476,280
4,860 Added 27.53%
22,512 $2.06 Million
Q1 2020

May 13, 2020
SELL
$62.82 - $91.86 $21,358 - $31,232
-340 Reduced 1.89%
17,652 $1.39 Million
Q4 2019

Feb 07, 2020
SELL
$78.51 - $87.4 $1.09 Million - $1.22 Million
-13,920 Reduced 43.62%
17,992 $1.56 Million
Q3 2019

Nov 12, 2019
BUY
$81.84 - $88.74 $174,973 - $189,726
2,138 Added 7.18%
31,912 $2.67 Million
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $104,874 - $122,315
-1,439 Reduced 4.61%
29,774 $2.5 Million
Q1 2019

May 10, 2019
BUY
$66.22 - $80.06 $1.25 Million - $1.52 Million
18,925 Added 154.01%
31,213 $2.5 Million
Q4 2018

Feb 14, 2019
SELL
$65.56 - $74.27 $29,174 - $33,050
-445 Reduced 3.49%
12,288 $888,000
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $60,627 - $73,139
997 Added 8.5%
12,733 $934,000
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $14,450 - $15,948
-251 Reduced 2.09%
11,736 $715,000
Q1 2018

May 10, 2018
BUY
$56.27 - $63.62 $352,756 - $398,833
6,269 Added 109.64%
11,987 $718,000
Q4 2017

Feb 15, 2018
SELL
$53.68 - $57.47 $1,610 - $1,724
-30 Reduced 0.52%
5,718 $326,000
Q3 2017

Nov 13, 2017
SELL
$48.06 - $53.64 $245,826 - $274,368
-5,115 Reduced 47.09%
5,748 $311,000
Q4 2016

Sep 21, 2017
BUY
N/A
10,863
10,863 $417,000

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.31B
Call Options Held
8.74M
Put Options Held
7.89M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email